Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K., Pett, S., Phillips, A. N., Polizzotto, M. N., Reilly, C., Sandkovsky, U., Sharma, S., Teitelbaum, M., Thompson, B. T., Young, B. E., Neaton, J. D., & Lundgren, J. D. (2022). design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Clinical trials, 19, 52–61. http://access.bl.uk/ark:/81055/vdc_100143836534.0x00000c